S. Ba s´ , Ł. Wo z´ niak, J. Cygan, J. Mlynarski
FULL PAPER
(
(
2S,3R)-1-(Furan-2-yl)-2,3-dihydroxyheptan-1-one (7h):[15] 1H NMR
300 MHz, CDCl ): δ = 7.66 (dd, J = 1.7, 0.8 Hz, 1 H), 7.38 (dd,
135.3, 134.9, 129.5, 128.9, 128.8, 128.1, 127.4, 127.1, 125.9, 125.8,
121.5, 73.8, 73.8, 40.9 ppm. IR (neat): ν˜ = 3453, 3063, 3023, 2928,
2850, 1695, 1496, 1455, 1413, 1329, 1261, 1173, 1135, 1069, 1017,
3
J = 3.7, 0.8 Hz, 1 H), 6.62 (dd, J = 3.6, 1.7 Hz, 1 H), 4.78 (s, 1 H),
4
1
–
1
.11 (t, J = 6.0 Hz, 1 H), 3.78 (d, J = 4.5 Hz, 1 H), 2.37 (s, 1 H), 986, 871, 755, 743, 705 cm . HPLC (Chiralpak AD-H, hexane/
.80–1.68 (m, 2 H), 1.62–1.33 (m, 4 H), 0.96 (t, J = 7.1 Hz, 3 iPrOH = 80:20, flow rate: 1.0 mL/min, λ = 254 nm): t = 11.7 (syn,
minor), 12.3 (syn, major), 17.3 (anti), 18.7 min (anti). HRMS (ESI):
calcd. for C17
[M + Na]+ 347.0871; found 347.0810.
R
13
H) ppm. C NMR (75 MHz, CDCl
19.4, 112.9, 76.0, 72.9, 34.4, 28.1, 22.8, 14.2 ppm. HPLC (Chi-
ralpak AD-H, hexane/iPrOH = 80:20, flow rate: 1.0 mL/min, λ =
54 nm): t = 10.2 (anti), 11.2 (anti), 13.3 (syn, major), 15.9 min
syn, minor).
3
): δ = 188.7, 150.6, 147.2,
1
15 3 3
H F O
(
2S,3R)-1-[3,5-Bis(trifluoromethyl)phenyl]-2,3-dihydroxy-4-phen-
2
(
R
1
ylbutan-1-one (7n): H NMR (300 MHz, CDCl
3
): δ = 8.07 (s, 2 H),
7
.47–7.20 (m, 6 H), 4.90 (d, J = 1.3 Hz, 1 H), 4.17 (ddd, J = 8.7,
1
3
(
2S,3R)-4-(Benzyloxy)-1-(furan-2-yl)-2,3-dihydroxybutan-1-one (7i):
6.4, 1.3 Hz, 1 H), 3.12–2.95 (m, 2 H) ppm. C NMR (75 MHz,
CDCl ): δ = 197.9, 136.8, 135.1, 132.8, 132.4, 129.2, 129.2, 128.6,
1
H NMR (300 MHz, CDCl
.47–7.29 (m, 6 H), 6.60 (dd, J = 3.6, 1.7 Hz, 1 H), 4.95 (d, J =
.9 Hz, 1 H), 4.62 (s, 2 H), 4.35 (td, J = 6.2, 1.9 Hz, 1 H), 3.81–
3
): δ = 7.65 (dd, J = 1.7, 0.5 Hz, 1 H),
3
7
1
3
1
7
2
1
127.2, 126.9, 124.4, 120.8, 73.8, 73.73, 40.6 ppm. IR (neat): ν˜ =
3492, 3360, 3093, 3066, 3029, 2927, 2855, 1695, 1614, 1497, 1456,
13
.65 (m, 2 H) ppm. C NMR (75 MHz, CDCl
3
): δ = 187.9, 150.4, 1406, 1376, 1288, 1258, 1191, 1145, 1060, 914, 946, 783, 752, 701,
–
1
47.4, 137.9, 128.6, 128.5, 127.9, 127.9, 127.4, 119.8, 112.8, 73.9,
3.7, 71.4, 71.2 ppm. IR (neat): ν˜ = 3297, 3126, 3032, 2935, 2886, rate: 0.5 mL/min, λ = 206 nm): t
859, 1704, 1670, 1570, 1490, 1468, 1417, 1392, 1318, 1236, 1138, (syn, minor), 34.1 min (syn, major). HRMS (ESI): calcd. for
[M + Na]+ 415.0745; found 415.0658.
682 cm . HPLC (Chiralpak OD-H, hexane/iPrOH = 96:4, flow
R
= 11.7 (anti), 15.8 (anti), 30.5
–1
118, 1080, 1033, 985, 885, 860, 772, 758, 734, 696 cm . HPLC
Chiralpak AD-H, hexane/iPrOH = 80:20, flow rate: 1.0 mL/min,
λ = 254 nm): t = 15.6 (anti), 16.9 (anti), 19.1 (syn, major), 23.5 min
syn, minor). HRMS (ESI): calcd. for C15
[M + Na]+
18 14 6 3
C H F O
(
(
2S,3R)-2,3-Dihydroxy-1-(2,3,5,6-tetrafluoro-4-methoxyphenyl)-
R
1
heptan-1-one (7o): H NMR (300 MHz, CDCl
3
3
3
): δ = 4.71 (dd, J =
.9, 2.0 Hz, 1 H), 4.21 (t, J = 1.9 Hz, 3 H), 4.17–4.07 (m, 2 H),
.92–3.83 (m, 1 H), 1.75–1.65 (m, 2 H), 1.50–1.29 (m, 5 H), 0.94
(
2
16 5
H O
99.0895; found 299.0873.
1
3
(
(
2S,3R)-4-(Benzyloxy)-1-(4-chlorophenyl)-2,3-dihydroxybutan-1-one
7j): H NMR (600 MHz, CDCl
(t, J = 7.0 Hz, 3 H) ppm. C NMR (75 MHz, CDCl
): δ = 7.89–7.84 (m, 2 H), 7.46– 79.6, 72.3, 62.0, 34.0, 27.8, 22.5, 13.9 ppm. IR (neat): ν˜ = 3331,
.41 (m, 2 H), 7.39–7.28 (m, 5 H), 5.19 (s, 1 H), 4.62–4.54 (m, 2 2955, 2872, 1706, 1648, 1510, 1487, 1440, 1408, 1330, 1309, 1202,
3
): δ = 195.4,
1
3
7
–
1
H), 4.16–4.10 (m, 1 H), 3.91 (s, 1 H), 3.66 (dd, J = 9.2, 6.9 Hz, 1
1161, 1092, 1003, 944, 915, 861, 811, 775, 689, 659 cm . HPLC
H), 3.62 (dd, J = 9.2, 5.8 Hz, 1 H), 2.32 (s, 1 H) ppm. 1 C NMR
3
(Chiralpak AD-H, hexane/iPrOH = 80:20, flow rate: 1.0 mL/min,
(
3 R
151 MHz, CDCl ): δ = 198.9, 140.7, 137.8, 132.1, 130.3, 129.4, λ = 254 nm): t = 5.4 (anti), 5.7 (anti), 7.8 (syn, major), 8.3 min
+
1
3
1
6
28.7, 128.1, 127.9, 73.7, 73.2, 71.4, 70.8 ppm. IR (neat): ν˜ = 3297,
16 4 4
(syn, minor). HRMS (ESI): calcd. for C14H F O [M + Na]
089, 3060, 3032, 2935, 2882, 1701, 1591, 1490, 1455, 1400, 1317,
255, 1214, 1134, 1096, 1029, 1014, 996, 983, 876, 867, 815, 740,
347.0882; found 347.0885.
(
2S,3R)-2,3-Dihydroxy-4-methyl-1-(2,3,5,6-tetrafluoro-4-methoxy-
–1
98 cm . HPLC (Chiralpak AD-H, hexane/iPrOH = 80:20, flow
= 13.9 (anti), 14.6 (anti), 15.4
syn, major), 16.3 min (syn, minor). HRMS (ESI): calcd. for
1
phenyl)pentan-1-one (7p): H NMR (300 MHz, CDCl
3
): δ = 4.88
rate: 1.0 mL/min, λ = 254 nm): t
(
R
(
d, J = 1.6 Hz, 1 H), 4.19 (t, J = 1.9 Hz, 3 H), 4.15–4.05 (m, 2 H),
3
6
.41 (dd, J = 8.9, 1.6 Hz, 1 H), 2.01–1.85 (m, 1 H), 1.03 (d, J =
.7 Hz, 6 H) ppm. C NMR (75 MHz, CDCl ): δ = 78.7, 78.5,
3
+
C
17
H17ClO
4
[M + Na] 243.0713; found 243.0710.
13
(
2S,3R)-4-(Benzyloxy)-2,3-dihydroxy-1-(4-trifluoromethylphenyl)-
62.7, 32.4, 19.7, 19.5 ppm. IR (neat): ν˜ = 3471, 2965, 2941, 2868,
1
butan-1-one (7k): H NMR (300 MHz, CDCl
3
): δ = 8.07–7.98 (m,
1708, 1650, 1511, 1491, 1440, 1412, 1314, 1203, 1141, 1097, 1068,
–
1
2
1
H), 7.79–7.69 (m, 2 H), 7.45–7.27 (m, 5 H), 5.23 (d, J = 1.9 Hz, 994, 802 cm . HPLC (Chiralpak AD-H, hexane/iPrOH = 80:20,
H), 4.57 (s, 2 H), 4.17–4.07 (m, 1 H), 3.75–3.58 (m, 2 H) ppm. flow rate: 1.0 mL/min, λ = 254 nm): t = 7.6 (anti), 9.2 (anti), 9.8
): δ = 199.9, 138.2, 137.3, 129.7, 129.3, (syn, minor), 11.3 min (syn, major). HRMS (ESI): calcd. for
R
1
3
C NMR (75 MHz, CDCl
3
1
7
1
9
29.2, 128.7, 128.6, 128.5, 128.4, 126.5, 126.5, 74.3, 74.2, 71.7,
1.2 ppm. IR (neat): ν˜ = 3331, 3063, 3032, 2929, 2874, 1708, 1615,
579, 1490, 1455, 1410, 1330, 1254, 1212, 1171, 1132, 1069, 1017,
C
13
H
14
F
4
O
4
[M + Na]+ 333.0726; found 333.0714.
(
2S,3R)-2,3-Dihydroxy-4,4-diphenyl-1-(2,3,5,6-tetrafluoro-4-meth-
1
oxyphenyl)lbutan-1-one (7q): H NMR (300 MHz, CDCl
3
): δ =
–
1
89, 874, 745, 699 cm . HPLC (Chiralpak AD-H, hexane/iPrOH
80:20, flow rate: 1.0 mL/min, λ = 254 nm): t = 9.9 (unseparated
anti), 11.5 (syn, major), 12.3 min (syn, minor). HRMS (ESI): calcd.
7
4
5
.44–7.14 (m, 10 H), 4.68–4.57 (m, 1 H), 4.54 (d, J = 4.0 Hz, 1 H),
=
R
.35 (d, J = 10.7 Hz, 1 H), 4.20 (t, J = 1.9 Hz, 3 H), 3.72 (d, J =
13
.7 Hz, 1 H), 1.89 (d, J = 6.3 Hz, 1 H) ppm. C NMR (75 MHz,
+
for C18
17 3 4
H F O [M + Na] 377.0977; found 377.0939.
3
CDCl ): δ = 195.4, 140.8, 140.5, 129.3, 129.1, 129.1, 128.6, 128.4,
(
2S,3R)-2,3-Dihydroxy-1-(4-trifluoromethylphenyl)butan-1-one (7l):
127.4, 127.3, 77.7, 74.5, 62.2, 55.1 ppm. IR (neat): ν˜ = 3482, 3084,
1
H NMR (300 MHz, CDCl
3
): δ = 8.12–7.97 (m, 2 H), 7.83–7.74 3062, 3030, 2959, 2928, 2850, 1709, 1648, 1598, 1511, 1491, 1453,
–1
(m, 2 H), 4.91 (d, J = 2.4 Hz, 1 H), 4.13 (m, 1 H), 1.39 (d, J =
1438, 1409, 1313, 1204, 1165 1124, 993, 812, 749, 707 cm . HPLC
13
6
1
2
8
8
1
.5 Hz, 3 H) ppm. C NMR (75 MHz, CDCl
3
): δ = 199.5, 136.9,
(Chiralpak AD-H, hexane/iPrOH = 80:20, flow rate: 1.0 mL/min,
R
29.0, 128.9, 125.9, 69.2, 68.8, 20.5 ppm. IR (neat): ν˜ = 3436, 2978, λ = 254 nm): t = 8.4 (syn, major), 15.7 (syn, minor), 17.5 (anti),
+
929, 1694, 1515, 1413, 1332 1269, 1173, 1137, 1069, 1011, 984,
18 4 4
18.6 min (anti). HRMS (ESI): calcd. for C23H F O [M + Na]
63, 847, 823 cm– . HPLC (Chiralpak OD-H, hexane/iPrOH =
1
457.1039; found 457.1020.
0:20, flow rate: 0.5 mL/min, λ = 254 nm): t
R
= 11.8 (syn, major),
(
2S,3R)-2,3-Dihydroxy-5-phenyl-1-(2,3,5,6-tetrafluoro-4-methoxy-
2.9 (syn, minor), 15.1 min (unseparated anti). HRMS (ESI): calcd.
1
phenyl)pentan-1-one (7r): H NMR (300 MHz, CDCl
.08 (m, 5 H), 4.67 (s, 1 H), 4.21 (t, J = 2.1 Hz, 3 H), 3.94–3.82
(m, 1 H), 3.78 (s, 1 H), 3.32 (s, 1 H), 2.88–2.65 (m, 2 H), 2.11–1.95
3
): δ = 7.35–
+
for C11
H
11
F
3
O
3
[M + Na] 271.0558; found 271.0493.
7
(
2S,3R)-2,3-Dihydroxy-4-phenyl-1-(4-trifluoromethylphenyl)butan-
1
13
1
7
2
-one (7m): H NMR (300 MHz, CDCl
.45–7.26 (m, 5 H), 4.92 (s, 1 H), 4.19–4.08 (m, 1 H), 3.12–2.95 (m,
H) ppm. 13C NMR (75 MHz, CDCl
): δ = 199.4, 137.2, 136.3,
3 3
): δ = 7.75–7.62 (m, 4 H), (m, 2 H) ppm. C NMR (75 MHz, CDCl ): δ = 195.3, 141.2,
128.6, 128.5, 126.2, 79.7, 71.7, 69.9, 62.2, 35.9, 32.0 ppm. IR (neat):
ν˜ = 3452, 3028, 2959, 2856, 1711, 1648, 1512, 1488, 1456, 1439,
3
6922
www.eurjoc.org
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2013, 6917–6923